Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
Fierce Biotech21h
Visby Medical nets FDA clearance for completely at-home STI test
The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
Milestone Pharmaceuticals announces FDA issued CRL for etripamil
Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...
Endovascular Today1d
Vasorum’s Celt ACD Plus Vascular Closure Device Approved by FDA
Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
We are excited to present four posters with important real-world data from our differentiated pain portfolio at PainConnect 2025 and are grateful to AAPM for selecting our poster at its meeting as a ...
Medical Device Network on MSN2d
MedCAD secures FDA 510(k) clearance for AccuStride foot and ankle system
The AccuStride System is intended to enhance surgical outcomes for proximal phalanx and metatarsal arthroplasty.
Townhall6dOpinion
Texas May Be Bringing Ibogaine Therapy to the U.S.
And Texas, spurred by a crusading longtime former governor, has the upper hand in bringing Ibogaine to the United States.
JD Supra8d
Food and Beverage News and Trends - March 2025 #2
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape.
Stockhead10d
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks
Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.